I hope I won’t end up like the mice in Kim’s diabetes research studies, but I am seriously considering participating in an upcoming study through my endocrinologist’s practice.
I got a flyer in the mail a few days before my doctor’s appointment last week advertising the study. The only requirement listed was that you have Type 1 diabetes and manage it with an insulin pump. I was curious but didn’t think too much about it.
During my appointment, I was discussing a possible pump switch with my endocrinologist and she mentioned the study. It turns out they will be comparing the MiniMed Revel with the MiniMed Veo (currently approved everywhere that does not include the FDA). I think it would be awesome to try out the Veo and hopefully contribute to the research the FDA apparently needs to determine it is safe for use in the US but unfortunately my doctor and I have no “control” over whether or not I am in the “control” group.
So far, I have figured out a few pros and cons about being in the study and I am trying to figure out how important each one is for me.
- There is the potential that I get to try out the MiniMed Veo insulin pump and the low glucose suspend feature.
- In the control or study group, I would receive a brand new pump and all my supplies paid for during the six month study. That is not a small amount of money.
- Maybe, just maybe I would be contributing to the research that would help to get a feature on the market in the US that so many people are hoping will keep themselves or their family members safer.
- I currently wear the DexCom CGM system and for the study I would need to switch to the MiniMed integrated CGM system. I have worn it before for trial periods, and found it to be uncomfortable at times.
- I found out during my follow-up phone call this week that the only insulins that are allowed in the study are Humalog and Novolog. I would need to switch from Apidra to one of those insulins. If I enroll in the study, I will not return to Humalog (trouble with tails), but am considering the switch to Novolog.
- I could end up in the control group with a pump and CGM I don’t necessarily want, on an insulin I don’t necessarily want to take. Do I then just drop out of the study?
- During the six month study I would be required to visit the office for once a month appointments. That is not a huge inconvenience as the office is about 2 miles from my current job. I did find out that the first appointment will be 4 hours, as I will be required to drink a Boost meal replacement drink and will have my blood drawn to measure digestion and glucose levels. I already cleared the appointments with my boss, but just because I CAN take time off work doesn’t mean I necessarily WANT to miss that much work time.
Random points of information:
- Due to some upcoming travel and their appointment schedule, I won’t actually go in for my first appointment until mid-April.
- They are sending me a packet in the mail with more information for me to fill out before my appointment.
- They require that I test four times a day during the study (ha! not a problem) and upload my information to Carelink each week (currently would need to be done on my work computer as I am running Lion on my Mac).
- I forgot to ask if I would have to switch infusion sets during the study. If I have to switch from the Sure-Ts, I am pretty sure I would not be willing to do that and would choose not to participate.
It’s still really early, but I figure all the feedback, support, and information I can get from all of you will be helpful. Plus, I don’t think it’s too often that members of our community have the opportunity to participate in things studies like this so hopefully I can continue to track the process.